Literature DB >> 19716806

High extracellular glucose inhibits exocytosis through disruption of syntaxin 1A-containing lipid rafts.

Sangeeta Somanath1, Sebastian Barg, Catriona Marshall, Christopher J Silwood, Mark D Turner.   

Abstract

Diabetes is characterized by high blood glucose which eventually impairs the secretion of insulin. Glucose directly affects cholesterol biosynthesis and may in turn affect cellular structures that depend on the sterol, including lipid rafts that help organize the secretory apparatus. Here, we investigated the long-term effects of glucose upon lipid rafts and secretory granule dynamics in pancreatic beta-cells. Raft fractions, identified by the presence of GM1 and flotillin, contained characteristically high levels of cholesterol and syntaxin 1A, the t-SNARE which tethers granules to the plasma membrane. Seventy-two hours exposure to 28mM glucose resulted in approximately 30% reduction in membrane cholesterol, with consequent redistribution of raft markers and syntaxin 1A throughout the plasma membrane. Live cell imaging indicated loss of syntaxin 1A from granule docking sites, and fewer docked granules. In conclusion, glucose-mediated inhibition of cholesterol biosynthesis perturbs lipid raft stability, resulting in a loss of syntaxin 1A from granule docking sites and inhibition of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716806     DOI: 10.1016/j.bbrc.2009.08.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.

Authors:  Jianguo Lin; Anping Chen
Journal:  Mol Cell Endocrinol       Date:  2010-12-30       Impact factor: 4.102

2.  Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells.

Authors:  Yuchen Wang; Rachel E Jarrard; Evan P S Pratt; Marcy L Guerra; Amy E Salyer; Allison M Lange; Ian M Soderling; Gregory H Hockerman
Journal:  Mol Endocrinol       Date:  2014-02-07

3.  Glucose-induced ERM protein activation and translocation regulates insulin secretion.

Authors:  James P Lopez; Jerrold R Turner; Louis H Philipson
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

4.  Man overboard! Rescuing myocardium with membrane rafts.

Authors:  Nicole Lohr; Judy R Kersten
Journal:  Anesthesiology       Date:  2010-05       Impact factor: 7.892

Review 5.  The fusion pore, 60 years after the first cartoon.

Authors:  Satyan Sharma; Manfred Lindau
Journal:  FEBS Lett       Date:  2018-07-02       Impact factor: 4.124

6.  Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.

Authors:  Ines Baotic; Zhi-Dong Ge; Filip Sedlic; Adrian Coon; Dorothee Weihrauch; David C Warltier; Judy R Kersten
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-10       Impact factor: 4.733

7.  Possible protective effect of membrane lipid rafts against interleukin-1β-mediated anti-proliferative effect in INS-1 cells.

Authors:  Myriam Chentouf; Caroline Guzman; Moustafa Hamze; René Gross; Anne Dominique Lajoix; Sylvie Peraldi-Roux
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 8.  Cholesterol-enriched membrane rafts and insulin secretion.

Authors:  Ronald Dirkx; Michele Solimena
Journal:  J Diabetes Investig       Date:  2012-08-20       Impact factor: 4.232

9.  Cellular phosphoinositides and the maturation of bluetongue virus, a non-enveloped capsid virus.

Authors:  Bishnupriya Bhattacharya; Polly Roy
Journal:  Virol J       Date:  2013-03-05       Impact factor: 4.099

10.  Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose.

Authors:  Alessandra Puddu; Roberta Sanguineti; Fabrizio Montecucco; Giorgio L Viviani
Journal:  Mediators Inflamm       Date:  2014-02-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.